The New ClinicAll App Aims to Make Hospital Visits Hassle-Free for Patients

Food and Healthcare Press Releases Tuesday April 17, 2018 07:24
NEUSS, Germany--17 Apr--PRNewswire/InfoQuest
Benefit from the lastest developments in health technology with the ClinicAll App
Developed for iOS and Android, the new ClinicAll app lets previously unfulfilled wishes come true, giving users full access to a wide range of services.
(Photo: https://mma.prnewswire.com/media/676359/ClinicAll_app.jpg )

ClinicAll has already been successful in providing digitalized solutions for clinics. This expertise has led to the idea of making all the possibilities of this new technology available to all users - conveniently on any smartphone or tablet.

The ClinicAll app makes sure users are the center of attention

During a hospital stay, the ClinicAll app enables the use of TV, Internet, and to call up all hospital information such as treatment appointments, meals, room lighting or bed control. Doctors and staff can inform the patient about upcoming visits via push messages. The app can also be used to call a nurse at any time - making it easy and uncomplicated to communicate with hospital staff.

After the stay, the ClinicAll app provides interesting news and information on the topics of health technology, ClinicAll, affiliated clinics and partners.
Available now in the App store - discover all the benefits live at conhIT 2018:
The ClinicAll app has now been released in the Android and iOS App stores. To date, no other supplier on the market has been able to realize an app for patients and clinics with a comparable range of features.
In order to install, search through the App store for "ClinicAll App".
The new ClinicAll app will be shown to industry representatives for the first time in our own virtual hospital set-up at conhIT 2018 - with some first applications.
Contact:
ClinicAll Germany GmbH,
Lea Kelic,
+49-2131 52813-30
lk@clinicall.de
Source: ClinicAll

Latest Press Release

Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by maintenance therapy of avelumab in...

UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says

Today on World Oral Health Day (WOHD), FDI World Dental Federation (FDI) released the results of a survey from 13 countries, which asked parents with children aged 5–16 if their child's school provided lessons on good oral care. Poor oral health...

Merck Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology

- Collaboration agreement enables Merck access to Iktos AI technology across three drug discovery projects - Generative modelling AI technology enables rapid and cost-effective design of novel drugs - Agreement is part of Merck's R&D strategy to...

Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Environment

Oxford Nanopore has today made Flongle starter packs available to purchase https://store.nanoporetech.com/flongle.html, after initial testing in an early-access programme. Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing...

FDI: Endodontics White Paper Calls for Treatment to Consider Impact on Patient Health and Well-being

FDI World Dental Federation (FDI) released its first white paper on endodontic care today, providing an important resource for dentists, national dental associations (NDAs) and other oral health actors. (Logo:...

Related Topics